Abstract
A high incidence of toxic nodular goiter has recently been described in areas of relatively low iodine intake. We studied the development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake (median 87 μg/24 h). The material comprised a total of 557 patients admitted to our department in the period 1978–88. The follow-up material consisted of 214 patients with a median age of 55 yr (19–86). Eighty-eight percent were females. The period of observation was 33 months (1–205). All patients had technetium thyroid scans, serum T3, serum T4, T3 uptake test and serum TSH performed. TRH tests were performed in 58 patients. During the follow-up period 45 initially euthyroid patients became hyperthyroid (18%). The incidence increased with age, and the median age in the group, who developed hyperthyroidism, was 65 yr. An estimated minimal incidence of toxic nodular goiter was 23/100,000/yr. Contrary to previous assumption, hyperthyroidism developed frequently in elderly patients with nodular goiter in a low iodine intake area. Thyroid cancer was found in 13 patients corresponding an estimated incidence of 1.5/100,000/yr. The cancer incidence was very low compared to other nordic countries with high iodine intake. This finding may suggest a possible influence of iodine intake on the incidence of thyroid cancer.
Similar content being viewed by others
References
Studer H., Peter H.J., Gerber H. Toxic nodular goitre. J. Clin. Endocrinol. Metab. 14: 351, 1985.
Degroot L.J., Larsen P.R., Refetoff S., Stanbury J.B. The thyroid and its diseases. Ed. 5. Johns Wiley & Sons, New York, 1985, p. 732.
Laurberg P., Pedersen K.M., Vestergaard H., Sigurdsson G. High incidence of Plummer’s disease in the elderly population in a low iodine intake area, versus high incidence of Graves’ disease in the young in a high iodine intake area. J. Int. Med. 229: 415, 1991.
Hakulinen T., Andersen A.A., Malker B., Pukkala E., Schou G., Tulinius H. Trends in cancer incidence in the Nordic Countries. Acta Pathol. Microbiol. Immunol. Scand. 94: 82, 1986.
Williams E.D., Doniach I., Bjarnason O., Michie W. Thyroid cancer in an iodide rich area. Cancer 39: 215, 1977.
Waterhouse J., Muir C.S., Shanmugaratnam K., Powel I. Cancer incidence in 5 continents: vol IV. IARC Scientific Publications, no. 42, Lyon, 1982.
Lumholtz I.B., Loldrup Poulsen D., Siersbæk-Nielsen K., Friis T., Rogowski P., Kirkengaard C., Molholm Hansen J. Outcome of long-term antithyroid treatment and Graves’ disease in relation to iodine intake. Acta Endocrinol. (Copenh.) 84: 538, 1977.
Faber J., Kirkegaard C., Rasmussen B., Westh H., Busch-Sorensen M., Jensen I.W. Pituitary-thyroid axis in critical illness. J. Clin. Endocrinol. Metabol. 65: 315, 1977.
Kølendorf K., Moller Brøch B., Rogowski P. The influence of chronic renal failure on serum and urinary thyroid hormone levels. Acta Endocrinol. (Copenh.) 89: 80, 1978.
Kirkegaard C., Faber J., Friis T., Birk Lauridsen U., Rogowski P., Siersbæk-Nielsen K. Intravenous and peroral TRH stimulation in sporadic atoxic goitre. Acta Endocrinol. (Copenh.) 85: 508, 1977.
Bartalena L., Martino E., Velluzzi F., Piga M., Petrini L., Loviselli A., Grasso L., Pinchera A. The lack of nocturnal serum thyrotropin surge in patients with nontoxic goiter may predict the subsequent occurrence of hyperthyroidism. J. Clin. Endocrinol. Metabol. 73: 604, 1991.
Sandrock D., Olbricht T., Emrich D., Benkert G., Reinwein D. Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol. (Copenh.) 128: 51, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kristensen, H.L., Vadstrup, S., Knudsen, N. et al. Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake. J Endocrinol Invest 18, 41–43 (1995). https://doi.org/10.1007/BF03349695
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349695